Ирина Владимировна Осипова
Research Subjects
Research Interests
Ирина Владимировна Осипова has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Oksana N. Antropova
Altai State Medical University
3 shared publications - Pyrikova N.V. Pyrikova
Altai State Medical University
3 shared publications - Susanna M. Kharit
Federal Research and Clinical Center for Infectious Diseases; Saint Petersburg State Pediatric Medical University
3 shared publications - L. V. Borisova
Altai State Medical University
2 shared publications - Leyla Seymurovna Namazova-Baranova
Russian Scientific Surgery Center named after Academician B.V. Petrovskiy with the Russian Academy of Sciences, Moscow, Russia
2 shared publications - Nikita Andreevich Mozhgunov
City Clinical Hospital № 11
2 shared publications
Latest Publications
- 13 July 2026
- Published by Bionika Media in Therapy
- Vol. 5_2026
A clinical case of oligosymptomatic «amiodaron lung» clinical course
- 13 July 2026
- Published by Bionika Media in Therapy
- Vol. 5_2026
A clinical case of oligosymptomatic «amiodaron lung» clinical course
- 9 December 2024
- Published by Bionika Media in Therapy
- Vol. 9_2024
Estimation of the prognostic role of patients’ adhesion to treatment and Charlson comorbidity index as predictors of chronic heart failure decompensation
- 9 December 2024
- Published by Bionika Media in Therapy
- Vol. 9_2024
Estimation of the prognostic role of patients’ adhesion to treatment and Charlson comorbidity index as predictors of chronic heart failure decompensation
- Open Access
- 6 December 2024
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (4) , 23-31
The role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol
Backround. A progress in Tcell acute lymphoblastic leukemia (TALL) treatment has been achieved in recent years by use a combination of riskadopted chemoradiation therapy, based on highdose (5000 mg/m2) methotrexate. A prerequisite for successful therapy is carefully follow supportive care principles and recommendations, which include blood serum methotrexate concentration monitoring, leucovorin rescue and alkaline solutions use for the best methotrexate elimination and decrease its toxic effects.Aim. To assess the effectiveness of ALL ICFM 2002 protocol based on highdose methotrexate for Tcell acute lymphoblastic leukemia.Materials and methods. From 2003 to 2023 in retroprospective study 67 patients with primary diagnosed TALL were enrolled. Median age was 7.4 years (from 0 to 18 years). All the patients were treated according to riskadopted ALL ICFM 2002 protocol. The therapy efficacy was assessed by overall (OS), eventfree (EFS) and relapsefree survival analysis. The survival rates were calculated with statistic program SSS 21.0 by Kaplan–Meier method.Results. The use of highdose methotrexate for TALL treatment in ALL ICFM 2002 protocol secure high survival rates: 10‑year OS was 82.5 ± 3 %, EFS – 79.3 ± 3 %. Analyzing OS and EFS depending on prognostic risk group we found that standard risk patients had OS and EFS 85.4 ± 6.9 and 78.4 ± 8 %, intermediate – 85.6 ± 6.7 and 82 ± 7.3 % and highrisk – 34.6 ± 18.3 and 20.8 ± 17.1 % respectively (р 0.05).Conclusion. ALL ICFM 2002 protocol for TALL includes highdose (5000 mg/m2) methotrexate is an effective for standard and intermediate risk patients, but for TALL patients with unfavorable prognostic factors it is necessary a therapy modification by additional cytotoxic and targeted options (nelarabine and daratumumab) inclusion and widening the indications for allogeneic stem cell transplantation.
- 6 December 2024
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (4) , 23-31
Open AccessThe role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol
Backround. A progress in Tcell acute lymphoblastic leukemia (TALL) treatment has been achieved in recent years by use a combination of riskadopted chemoradiation therapy, based on highdose (5000 mg/m2) methotrexate. A prerequisite for successful therapy is carefully follow supportive care principles and recommendations, which include blood serum methotrexate concentration monitoring, leucovorin rescue and alkaline solutions use for the best methotrexate elimination and decrease its toxic effects.Aim. To assess the effectiveness of ALL ICFM 2002 protocol based on highdose methotrexate for Tcell acute lymphoblastic leukemia.Materials and methods. From 2003 to 2023 in retroprospective study 67 patients with primary diagnosed TALL were enrolled. Median age was 7.4 years (from 0 to 18 years). All the patients were treated according to riskadopted ALL ICFM 2002 protocol. The therapy efficacy was assessed by overall (OS), eventfree (EFS) and relapsefree survival analysis. The survival rates were calculated with statistic program SSS 21.0 by Kaplan–Meier method.Results. The use of highdose methotrexate for TALL treatment in ALL ICFM 2002 protocol secure high survival rates: 10‑year OS was 82.5 ± 3 %, EFS – 79.3 ± 3 %. Analyzing OS and EFS depending on prognostic risk group we found that standard risk patients had OS and EFS 85.4 ± 6.9 and 78.4 ± 8 %, intermediate – 85.6 ± 6.7 and 82 ± 7.3 % and highrisk – 34.6 ± 18.3 and 20.8 ± 17.1 % respectively (р 0.05).Conclusion. ALL ICFM 2002 protocol for TALL includes highdose (5000 mg/m2) methotrexate is an effective for standard and intermediate risk patients, but for TALL patients with unfavorable prognostic factors it is necessary a therapy modification by additional cytotoxic and targeted options (nelarabine and daratumumab) inclusion and widening the indications for allogeneic stem cell transplantation.
- 22 June 2023
- Published by Bionika Media in Therapy
- Vol. 4_2023
Results of a 12-month telemonitoring of chronic heart failure patients after hospitalization with its decompensation
- 22 June 2023
- Published by Bionika Media in Therapy
- Vol. 4_2023
Results of a 12-month telemonitoring of chronic heart failure patients after hospitalization with its decompensation
- Open Access
- 9 January 2023
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 21 (6) , 65-81
Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study
Relevance. Invasive meningococcal disease (IMD) has high morbidity and mortality, with infants and young children among those at greatest risk.Materials & Methods. A phase III, open-label, randomized study in toddlers aged 12–23 months evaluated the immunogenicity and safety of MenACYWTT, a tetanus toxoid conjugated vaccine against meningococcal serogroups A, C, W, and Y, when coadministered with paediatric vaccines (measles, mumps and rubella [MMR]; varicella [V] in South Korea and Thailand; 6in1 combination vaccine against diphtheria, tetanus, pertussis, polio, hepatitis B and Haemophilus influenzae type b [DTaPIPVHepBHib] in Mexico and pneumococcal conjugate vaccine [PCV13]) in the Russian Federation (NCT03205371). This manuscript reports the outcome of the part of the study conducted in the Russian Federation using PCV13 as the coadministered vaccine. Immunogenicity to each meningococcal serogroup was assessed by serum bactericidal antibody assay using human complement (hSBA) and, for a subset of subjects, baby rabbit complement (rSBA). Vaccine safety profiles were described up to 30 days postvaccination.Results. A total of 1,183 participants were enrolled in the study, out of which 400 were from the Russian Federation. The proportion with seroprotection (hSBA ≥1:8) to each meningococcal serogroup at Day 30 was comparable between the MenACYW-TT and MenACYW-TT + PCV13 groups (≥91% and ≥84%, respectively). The safety profiles of MenACYW-TT and PCV13, when given alone or concomitantly, were generally comparable.Conclusion. Coadministration of MenACYW-TT with pneumococcal conjugate vaccine in toddlers had no clinically relevant effect on the immunogenicity and safety of any of the vaccines.
- 9 January 2023
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 21 (6) , 65-81
Open AccessImmunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study
Relevance. Invasive meningococcal disease (IMD) has high morbidity and mortality, with infants and young children among those at greatest risk.Materials & Methods. A phase III, open-label, randomized study in toddlers aged 12–23 months evaluated the immunogenicity and safety of MenACYWTT, a tetanus toxoid conjugated vaccine against meningococcal serogroups A, C, W, and Y, when coadministered with paediatric vaccines (measles, mumps and rubella [MMR]; varicella [V] in South Korea and Thailand; 6in1 combination vaccine against diphtheria, tetanus, pertussis, polio, hepatitis B and Haemophilus influenzae type b [DTaPIPVHepBHib] in Mexico and pneumococcal conjugate vaccine [PCV13]) in the Russian Federation (NCT03205371). This manuscript reports the outcome of the part of the study conducted in the Russian Federation using PCV13 as the coadministered vaccine. Immunogenicity to each meningococcal serogroup was assessed by serum bactericidal antibody assay using human complement (hSBA) and, for a subset of subjects, baby rabbit complement (rSBA). Vaccine safety profiles were described up to 30 days postvaccination.Results. A total of 1,183 participants were enrolled in the study, out of which 400 were from the Russian Federation. The proportion with seroprotection (hSBA ≥1:8) to each meningococcal serogroup at Day 30 was comparable between the MenACYW-TT and MenACYW-TT + PCV13 groups (≥91% and ≥84%, respectively). The safety profiles of MenACYW-TT and PCV13, when given alone or concomitantly, were generally comparable.Conclusion. Coadministration of MenACYW-TT with pneumococcal conjugate vaccine in toddlers had no clinically relevant effect on the immunogenicity and safety of any of the vaccines.
- Open Access
- 1 January 2023
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 32 (4) , 94-104
VEGETATIVE DYSFUNCTION IN CHRONIC OPISTHORCHIASIS
Introduction. Altai Krai is one of the most significant natural foci of opisthorchiasis not only in Western Siberia, but also on the territory of the Russian Federation as a whole, where the incidence of opisthorchiasis ranges from 44 to 34 per 100,000 people. The primary habitat of opisthorchiasis is the hepatobiliary system; the polymorphism of long-term invasion polymorphism is characterized by a violation of the functions of many organs and systems: liver, immune and cardiovascular systems, digestive organs, etc. The control center responsible for these vital functions of the body is the autonomic nervous system, which regulates them in the body. Analysis of heart rate variability can give an idea of sympathetic-parasympathetic vegetative balance. The purpose of the study. A comprehensive study of the state of autonomic regulation by analyzing heart rate variability in patients with chronic opisthorchiasis. Materials and methods. During the course of the study, 31 patients with chronic opisthorchiasis (CO) were observed, a comparison was made with 30 healthy individuals of similar age and gender. When studying the function of the autonomic nervous system, the method of mathematical analysis of the heart rate according to R.M. Baevsky was used with the help of the original program "CORVEG". The level of critical significance of the null statistical hypothesis was assumed to be 0.05. Results and Discussion. In the study of the nature of vegetative changes, methods of frequency and spectral analysis of heart rate were used. Changes in heart rate regulation indicators were statistically significantly (p<0.05) indicated an increase in sympathetic regulation at rest and orthostasis in patients with SC, their autonomic homeostasis was shifted toward the sympathetic nervous system both at rest and under load, and in some patients (31%) dysregulation of the central type was detected. Conclusions. Dysregulation of autonomic nervous system in patients with chronic opisthorchiasis was revealed at all levels of its regulation and was characterized by increased sympathetic tone and a decrease in parasympathetic and humoral regulation, as well as vasoreflective and baroreflective mechanisms.
- 1 January 2023
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 32 (4) , 94-104
Open AccessVEGETATIVE DYSFUNCTION IN CHRONIC OPISTHORCHIASIS
Introduction. Altai Krai is one of the most significant natural foci of opisthorchiasis not only in Western Siberia, but also on the territory of the Russian Federation as a whole, where the incidence of opisthorchiasis ranges from 44 to 34 per 100,000 people. The primary habitat of opisthorchiasis is the hepatobiliary system; the polymorphism of long-term invasion polymorphism is characterized by a violation of the functions of many organs and systems: liver, immune and cardiovascular systems, digestive organs, etc. The control center responsible for these vital functions of the body is the autonomic nervous system, which regulates them in the body. Analysis of heart rate variability can give an idea of sympathetic-parasympathetic vegetative balance. The purpose of the study. A comprehensive study of the state of autonomic regulation by analyzing heart rate variability in patients with chronic opisthorchiasis. Materials and methods. During the course of the study, 31 patients with chronic opisthorchiasis (CO) were observed, a comparison was made with 30 healthy individuals of similar age and gender. When studying the function of the autonomic nervous system, the method of mathematical analysis of the heart rate according to R.M. Baevsky was used with the help of the original program "CORVEG". The level of critical significance of the null statistical hypothesis was assumed to be 0.05. Results and Discussion. In the study of the nature of vegetative changes, methods of frequency and spectral analysis of heart rate were used. Changes in heart rate regulation indicators were statistically significantly (p<0.05) indicated an increase in sympathetic regulation at rest and orthostasis in patients with SC, their autonomic homeostasis was shifted toward the sympathetic nervous system both at rest and under load, and in some patients (31%) dysregulation of the central type was detected. Conclusions. Dysregulation of autonomic nervous system in patients with chronic opisthorchiasis was revealed at all levels of its regulation and was characterized by increased sympathetic tone and a decrease in parasympathetic and humoral regulation, as well as vasoreflective and baroreflective mechanisms.
- 14 May 2020
- Published by Bionika Media in Therapy
- Vol. 3_2020
Clinical significance of non-cardial comboridity in patients with chronic heart failure
- 14 May 2020
- Published by Bionika Media in Therapy
- Vol. 3_2020
Clinical significance of non-cardial comboridity in patients with chronic heart failure
- Open Access
- 26 June 2019
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 18 (3) , 28-39
Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
Безопасность и иммуногенность полностью жидкой шестивалентной вакцины АбКДС-ИПВ-ГепВ-Hib у здоровых детей 1-го года жизни в Российской Федерации
- 26 June 2019
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 18 (3) , 28-39
Open AccessSafety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
Безопасность и иммуногенность полностью жидкой шестивалентной вакцины АбКДС-ИПВ-ГепВ-Hib у здоровых детей 1-го года жизни в Российской Федерации
- Open Access
- 13 June 2019
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 18 (3) , 11-17
Predictors of hypertension in women with rheumatoid arthritis
Aim. To determine the set of significant risk factors for arterial hypertension (AH) in women with rheumatoid arthritis (RA).Material and methods. The study included two groups of patients with RA: group 1 — women with AH (n=162), group 2 women without AH (n=61). Clinical, laboratory, instrumental examination of patients and determination of risk factors (RF) for cardiovascular diseases (CVD) in RA were provided according to Association of Rheumatologists of Russia (ARR 2017) and the Russian Society of Cardiology (RSC, 2017) guidelines. Salt taste sensitivity threshold (STST) was studied with R. J. Henkin’s modified method. The analysis of the internal body fluids was made with bioimpedance analysis. The glomerular filtration rate (GFR) was estimated with MDRD equation (K/DOQI, 2002). Statistical data were obtained with “Statistica 10” software. Logit regression analysis was used to identify the correlation between RF and AH.Results. The predictors of AH in RA were: age over 55 years (p=0,001), early menopause (p=0,001), increased total blood cholesterol (р=0,001), prednisolone intake more than 10 mg/day (p=0,001), early family history of CVD (p=0,01), decreased GFR less than 60 ml/min/1,73 m. (p=0,01), high STST (p=0,01), unbalanced nutrition (p=0,01), pregnancy pathology (p=0,01), high activity of the inflammatory process (p=0,01), psychosocial factors (stress, anxiety, depression) (p=0,01), obesity (p=0,01), duration of RA more than 10 years (p=0,01). There were 2 times more salt-sensitive patients among women with RA and AH than those with RA and without AH (87 and 48%, respectively). Increased fluid in the body was observed with decreased natriuresis; it implied the presence of volume-dependent hypertension (VDH).Conclusion. The study demonstrated the significance of determining the set of predictors such as cardiometabolic, gender, psychosocial, disease-mediated, renal ones. The importance of STST in RA is evident. The information about AH predictors allows to create individual recommendations to correct modifiable RF and prescribe therapy for women with RA. The conducted research will enable to optimize the follow-up process of the patients and reduce the mortality from cardiovascular complications.
- 13 June 2019
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 18 (3) , 11-17
Open AccessPredictors of hypertension in women with rheumatoid arthritis
Aim. To determine the set of significant risk factors for arterial hypertension (AH) in women with rheumatoid arthritis (RA).Material and methods. The study included two groups of patients with RA: group 1 — women with AH (n=162), group 2 women without AH (n=61). Clinical, laboratory, instrumental examination of patients and determination of risk factors (RF) for cardiovascular diseases (CVD) in RA were provided according to Association of Rheumatologists of Russia (ARR 2017) and the Russian Society of Cardiology (RSC, 2017) guidelines. Salt taste sensitivity threshold (STST) was studied with R. J. Henkin’s modified method. The analysis of the internal body fluids was made with bioimpedance analysis. The glomerular filtration rate (GFR) was estimated with MDRD equation (K/DOQI, 2002). Statistical data were obtained with “Statistica 10” software. Logit regression analysis was used to identify the correlation between RF and AH.Results. The predictors of AH in RA were: age over 55 years (p=0,001), early menopause (p=0,001), increased total blood cholesterol (р=0,001), prednisolone intake more than 10 mg/day (p=0,001), early family history of CVD (p=0,01), decreased GFR less than 60 ml/min/1,73 m. (p=0,01), high STST (p=0,01), unbalanced nutrition (p=0,01), pregnancy pathology (p=0,01), high activity of the inflammatory process (p=0,01), psychosocial factors (stress, anxiety, depression) (p=0,01), obesity (p=0,01), duration of RA more than 10 years (p=0,01). There were 2 times more salt-sensitive patients among women with RA and AH than those with RA and without AH (87 and 48%, respectively). Increased fluid in the body was observed with decreased natriuresis; it implied the presence of volume-dependent hypertension (VDH).Conclusion. The study demonstrated the significance of determining the set of predictors such as cardiometabolic, gender, psychosocial, disease-mediated, renal ones. The importance of STST in RA is evident. The information about AH predictors allows to create individual recommendations to correct modifiable RF and prescribe therapy for women with RA. The conducted research will enable to optimize the follow-up process of the patients and reduce the mortality from cardiovascular complications.